FDA Inspection 1087302 — Covis Pharma GmBH
The FDA completed an inspection of Covis Pharma GmBH on April 5, 2019 in Waltham, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 5, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Waltham, MA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)